20 An audit of docetaxel for 2nd line treatment of patients with advanced non small cell lung cancer (NSCLC): toxicities and outcomes in NHS Tayside 2005–2010
Capaldi, S., Lord, H., Rankin, E.M., Brown, E.Volume:
75
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(12)70021-1
Date:
January, 2012
File:
PDF, 44 KB
english, 2012